We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Functional 3D Neural Network Models Generated from Stem Cells

By LabMedica International staff writers
Posted on 01 Nov 2018
Print article
Image: Confocal image of fluorescent markers indicating presence of neurons (green), astrocytes (red) and the silk protein-collagen matrix (blue). Image field is 460 microns (Photo courtesy of Tufts University).
Image: Confocal image of fluorescent markers indicating presence of neurons (green), astrocytes (red) and the silk protein-collagen matrix (blue). Image field is 460 microns (Photo courtesy of Tufts University).
A team of biomedical engineers worked with human induced pluripotent stem cells (iPSCs) to develop three-dimensional (3D) in vitro human neural network model systems.

Three-dimensional in vitro cell and tissue culture models allow for the exploration of mechanisms of organ development, cellular interactions, and disease progression within defined environments. Investigators at Tufts University (Boston, MA, USA) used iPSCs from normal and diseased individuals to populate a three-dimensional matrix of silk protein and collagen to create such models, which would mimic structural and functional features of the brain and demonstrate neural activity.

The current work was based on previous studies where primary rodent neurons were successfully grown in a similar three-dimensional system. The model was adapted to human induced pluripotent stem cells, allowing for a more direct exploration of the human condition.

The investigators reported in the October 1, 2018, online edition of the journal ACS Biomaterials Science & Engineering that these tissue cultures comprised diverse cell populations, including neurons and astroglial cells, interacting in three-dimensions and exhibited spontaneous neural activity confirmed through electrophysiological recordings and calcium imaging over at least nine months. Compared to growing and culturing cells in two dimensions, the three-dimensional matrix produced a significantly more complete mix of cells found in neural tissue, with the appropriate morphology and expression of receptors and neurotransmitters.

This approach, which was tested with stem cells derived from healthy individuals as well as from Alzheimer’s and Parkinson’s disease patients, allowed for the direct integration of pluripotent stem cells into the three-dimensional construct, bypassing early neural differentiation steps. This streamlined process, in combination with the longevity of the cultures, provided a system that could be manipulated to support a variety of experimental applications such as investigating drug targets in neurodegenerative diseases.

"We found the right conditions to get the iPSCs to differentiate into a number of different neural subtypes, as well as astrocytes that support the growing neural networks," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University. "The silk-collagen scaffolds provide the right environment to produce cells with the genetic signatures and electrical signaling found in native neuronal tissues."

Related Links:
Tufts University

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.